期刊文献+

制备条件对丝裂霉素微囊载药量及释放度的影响 被引量:1

Effect of preparation conditions on the drug loading rate and release rate of mitomycin microcapsule
下载PDF
导出
摘要 目的:筛选制备高载药量和释放性能良好的丝裂霉素微囊的条件。方法:以溶剂非溶剂法制备了丝裂霉素微囊,用高效液相色谱法和紫外分光光度法测定丝裂霉素微囊载药量及释放度。结果:随着囊材用量减少,载药量升高,释放显现突释效应;随着吐温-80用量的增加,释放度逐渐加快,直至无规律释药;随着搅拌速度的加快,载药量先增加后减少,释放度增大。结论:以正己烷、环己烷为溶剂,最佳制备工艺条件是:0.8%的乙基纤维素,4%的吐温-80,100 r.min-1的搅拌速度。 Objective:To prepare mitomycin microcapsule with high drug loading rate and sustainedrelease character. Methods: Mitomycin microcapsule was prepared using solvent and solventless method. The concentrations and release rate of mitomycin were measured by HPLC and ultraviolet-visible spectrophotometry. Results: The results showed that the loading rates were increased as the ethylcellulose decreased; the release rate was increased as the tween-80 increased; the loading rates were increased in the beginning then decreased and release rate was increased as the churning speed was increased. Conclusion : The conditions of the best preparation technology are as follows : 0.8% ethylcellulose, 4% tween-80, churning speed of 100r· min^-1.
出处 《药学与临床研究》 2008年第6期478-480,共3页 Pharmaceutical and Clinical Research
基金 科技部技术创新基金项目(04C26213300548)
关键词 丝裂霉素微囊 制备条件 载药量 释放度 Mitomycin microcapsule Preparation conditions Drug loading rate Release rate
  • 相关文献

参考文献4

二级参考文献14

  • 1吴彩云,杨汝德,夏枫耿.新型高效微生态制品的研制[J].微生物学杂志,2002,22(5):32-34. 被引量:6
  • 2杜维波,李兰娟.肝细胞微囊化技术及其在生物型人工肝中的应用进展[J].国外医学(流行病学.传染病学分册),2005,32(4):208-210. 被引量:1
  • 3葛寒英.沙棘油的微囊化技术[J].东北林业大学学报,2005,33(5):115-116. 被引量:8
  • 4丁树平 曾进.膀胱上皮性肿瘤.现代泌尿肿瘤学[M].武汉:湖北科学技术出版社,1997.147-161.
  • 5李平 丁树平.BCG灌注和膀胱肾反流[J].国外医学:泌尿系统分册,1990,(4):192-192.
  • 6团体著者,中华人民共和国药典.2,1995年
  • 7周海钧,生物检定统计方法,1983年,42页
  • 8ORIVE G,HEMANDEZ R M,RODRIGAEZ-GASCON A,et al.History,challenges and perspectives of cell microencapsulation[J].Trends Biotechnol,2004,22(2):87 -92.
  • 9HAQUE T,CHEN H,OUYANG W,et al.In vitro study of alginatechitosan microcapsules:an alternative to liver cell transplants for the treatment of liver failure[J].Biotechnol Lett,2005,27 (5):317 -322.
  • 10顾秀芳,陈福安.丝裂霉素C静脉注射外漏致组织坏死1例[J]农垦医学,2000(06).

共引文献19

同被引文献13

  • 1周红玲,陈建海,艾秀娟,杨西晓,西娜,蒋青锋.微射流法制备注射用丝裂霉素纳米粒及其溶血试验研究[J].中国药房,2007,18(13):976-978. 被引量:2
  • 2韩德艳,谢长生.碳包铁对丝裂霉素C的吸附与缓释性能研究[J].化学与生物工程,2006,23(4):32-34. 被引量:5
  • 3侯振清,刘洋,叶社房,王衍戈,王倩,钟李明,金利华,张其清.植入式丝裂霉素控释膜剂的抑瘤作用[J].肿瘤,2007,27(3):202-204. 被引量:2
  • 4Bilensoy E, Sarisozen C, Esendagli G, et al. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomyein C to bladder tumors. Internat J of Pharmac, 2009, 37!: 170 - 176.
  • 5Mungan N, Sarisozen G, Dogan L, et ai. Broadhesive coated nanoparticles loaded with MIitomycin C for the effective chemotherapy of Superficial bladder cancer. Urology, 2008, 7:S67.
  • 6陈亭亭,陆伟根.透析法测定丝裂霉素多囊脂质体的包封率.第三届国际药物制剂论坛论文集,2007.
  • 7Karadeniz H, Alparslan L, Erdem A, et al. Electrochemical investigation of interaction between mltomycin C and DNA in a novel drug-delivery system. J Pharmac & Biomed Analysis, 45: 322,326.
  • 8Flamand N, Marrot L, Belaidi JP, et al. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: Towards new tools for in vitro risk assessment of dermally applied compounds. Mutation Research, 2006, 606:39 -51.
  • 9Curren RD, Sun GC, Gibson DP, et al. Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDermTM). Mutation Research,2006,607 : 192 - 204.
  • 10Hueman EM, Simpson CB, Texas SA,et al. Airway Complications from Topical Mitomycin C. Otolaryngology Head and Neck Surgery, 2005, 133:831-835.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部